AAPL337.00+4.59 (+1.38%) ▲|ABBV264.02+1.51 (+0.58%) ▲|ABT102.23-0.13 (-0.13%) ▼|ACN190.29+0.65 (+0.34%) ▲|ADBE252.67+2.17 (+0.87%) ▲|AMAT417.40+2.02 (+0.49%) ▲|AMD545.09+32.59 (+6.36%) ▲|AMGN379.78+3.43 (+0.91%) ▲|AMT175.58-0.81 (-0.46%) ▼|AMZN251.19+5.23 (+2.13%) ▲|AVGO347.30+7.79 (+2.29%) ▲|AXP311.17-1.26 (-0.40%) ▼|BA197.00-4.96 (-2.46%) ▼|BAC58.18+0.28 (+0.48%) ▲|BKNG170.52-0.88 (-0.51%) ▼|BLK1,053.96+16.72 (+1.61%) ▲|BMY62.84-0.76 (-1.20%) ▼|BNY153.02-0.45 (-0.29%) ▼|BRK-B509.20-10.60 (-2.04%) ▼|C132.70-0.25 (-0.19%) ▼|CAT798.57+15.85 (+2.03%) ▲|CL87.73+0.71 (+0.82%) ▲|CMCSA22.91-0.82 (-3.46%) ▼|COF202.04-1.15 (-0.57%) ▼|COP133.19+0.65 (+0.49%) ▲|COST893.93+0.19 (+0.02%) ▲|CRM242.85-7.25 (-2.90%) ▼|CSCO110.24+2.50 (+2.32%) ▲|CVS90.27-1.45 (-1.58%) ▼|CVX211.57+0.03 (+0.01%) ▲|DE685.63+16.16 (+2.41%) ▲|DHR212.50+4.14 (+1.99%) ▲|DIS105.35-1.64 (-1.53%) ▼|DUK118.54+0.78 (+0.66%) ▲|EMR147.40+1.57 (+1.08%) ▲|FDX305.88+4.16 (+1.38%) ▲|GD355.95-4.05 (-1.13%) ▼|GE313.47+0.57 (+0.18%) ▲|GEV924.93-0.16 (-0.02%) ▼|GILD150.89+3.21 (+2.17%) ▲|GM86.62+2.33 (+2.76%) ▲|GOOG343.68+4.32 (+1.27%) ▲|GOOGL347.33+4.46 (+1.30%) ▲|GS951.47+13.49 (+1.44%) ▲|HD302.51+0.04 (+0.01%) ▲|HON206.49-1.17 (-0.56%) ▼|IBM237.75+0.26 (+0.11%) ▲|INTC108.80+7.75 (+7.67%) ▲|INTU313.13-5.00 (-1.57%) ▼|ISRG383.54+1.25 (+0.33%) ▲|JNJ270.22+2.94 (+1.10%) ▲|JPM349.31+0.39 (+0.11%) ▲|KO88.06+0.19 (+0.22%) ▲|LIN458.48-3.61 (-0.78%) ▼|LLY1,152.44+14.62 (+1.28%) ▲|LMT538.09+0.84 (+0.16%) ▲|LOW194.19+0.09 (+0.05%) ▲|LRCX269.31+0.08 (+0.03%) ▲|MA565.73-2.02 (-0.36%) ▼|MCD248.48-0.08 (-0.03%) ▼|MDLZ62.04-0.32 (-0.51%) ▼|MDT92.77+0.17 (+0.18%) ▲|META682.31+9.00 (+1.34%) ▲|MMM164.71+2.06 (+1.27%) ▲|MO69.70-0.40 (-0.57%) ▼|MRK147.15+2.24 (+1.55%) ▲|MS203.52+1.10 (+0.54%) ▲|MSFT497.75+7.45 (+1.52%) ▲|MU977.50+50.95 (+5.50%) ▲|NEE81.28+0.91 (+1.13%) ▲|NFLX75.31-1.10 (-1.44%) ▼|NKE36.36+0.58 (+1.62%) ▲|NOW138.47-1.35 (-0.97%) ▼|NVDA219.34+5.44 (+2.54%) ▲|ORCL150.59+7.43 (+5.19%) ▲|PEP133.66-0.68 (-0.51%) ▼|PFE27.64+0.18 (+0.66%) ▲|PG147.55+0.53 (+0.36%) ▲|PLTR176.24+1.90 (+1.09%) ▲|PM190.48-1.23 (-0.64%) ▼|QCOM188.71+3.87 (+2.09%) ▲|RTX193.54-3.29 (-1.67%) ▼|SBUX96.67-0.67 (-0.69%) ▼|SCHW104.63-0.53 (-0.50%) ▼|SO86.76+0.53 (+0.61%) ▲|SPG204.47+1.53 (+0.75%) ▲|T25.39-0.47 (-1.82%) ▼|TMO658.32+9.89 (+1.53%) ▲|TMUS166.45-9.81 (-5.57%) ▼|TSLA366.20+8.12 (+2.27%) ▲|TXN258.14-2.53 (-0.97%) ▼|UBER70.87-0.10 (-0.14%) ▼|UNH375.21-0.05 (-0.01%) ▼|UNP282.48+1.56 (+0.56%) ▲|UPS100.17+1.40 (+1.42%) ▲|USB60.25+0.52 (+0.87%) ▲|V369.93-1.00 (-0.27%) ▼|VZ48.33-1.43 (-2.87%) ▼|WFC86.89-0.16 (-0.18%) ▼|WMT106.79-0.71 (-0.66%) ▼|XOM163.27-0.05 (-0.03%) ▼|AAPL337.00+4.59 (+1.38%) ▲|ABBV264.02+1.51 (+0.58%) ▲|ABT102.23-0.13 (-0.13%) ▼|ACN190.29+0.65 (+0.34%) ▲|ADBE252.67+2.17 (+0.87%) ▲|AMAT417.40+2.02 (+0.49%) ▲|AMD545.09+32.59 (+6.36%) ▲|AMGN379.78+3.43 (+0.91%) ▲|AMT175.58-0.81 (-0.46%) ▼|AMZN251.19+5.23 (+2.13%) ▲|AVGO347.30+7.79 (+2.29%) ▲|AXP311.17-1.26 (-0.40%) ▼|BA197.00-4.96 (-2.46%) ▼|BAC58.18+0.28 (+0.48%) ▲|BKNG170.52-0.88 (-0.51%) ▼|BLK1,053.96+16.72 (+1.61%) ▲|BMY62.84-0.76 (-1.20%) ▼|BNY153.02-0.45 (-0.29%) ▼|BRK-B509.20-10.60 (-2.04%) ▼|C132.70-0.25 (-0.19%) ▼|CAT798.57+15.85 (+2.03%) ▲|CL87.73+0.71 (+0.82%) ▲|CMCSA22.91-0.82 (-3.46%) ▼|COF202.04-1.15 (-0.57%) ▼|COP133.19+0.65 (+0.49%) ▲|COST893.93+0.19 (+0.02%) ▲|CRM242.85-7.25 (-2.90%) ▼|CSCO110.24+2.50 (+2.32%) ▲|CVS90.27-1.45 (-1.58%) ▼|CVX211.57+0.03 (+0.01%) ▲|DE685.63+16.16 (+2.41%) ▲|DHR212.50+4.14 (+1.99%) ▲|DIS105.35-1.64 (-1.53%) ▼|DUK118.54+0.78 (+0.66%) ▲|EMR147.40+1.57 (+1.08%) ▲|FDX305.88+4.16 (+1.38%) ▲|GD355.95-4.05 (-1.13%) ▼|GE313.47+0.57 (+0.18%) ▲|GEV924.93-0.16 (-0.02%) ▼|GILD150.89+3.21 (+2.17%) ▲|GM86.62+2.33 (+2.76%) ▲|GOOG343.68+4.32 (+1.27%) ▲|GOOGL347.33+4.46 (+1.30%) ▲|GS951.47+13.49 (+1.44%) ▲|HD302.51+0.04 (+0.01%) ▲|HON206.49-1.17 (-0.56%) ▼|IBM237.75+0.26 (+0.11%) ▲|INTC108.80+7.75 (+7.67%) ▲|INTU313.13-5.00 (-1.57%) ▼|ISRG383.54+1.25 (+0.33%) ▲|JNJ270.22+2.94 (+1.10%) ▲|JPM349.31+0.39 (+0.11%) ▲|KO88.06+0.19 (+0.22%) ▲|LIN458.48-3.61 (-0.78%) ▼|LLY1,152.44+14.62 (+1.28%) ▲|LMT538.09+0.84 (+0.16%) ▲|LOW194.19+0.09 (+0.05%) ▲|LRCX269.31+0.08 (+0.03%) ▲|MA565.73-2.02 (-0.36%) ▼|MCD248.48-0.08 (-0.03%) ▼|MDLZ62.04-0.32 (-0.51%) ▼|MDT92.77+0.17 (+0.18%) ▲|META682.31+9.00 (+1.34%) ▲|MMM164.71+2.06 (+1.27%) ▲|MO69.70-0.40 (-0.57%) ▼|MRK147.15+2.24 (+1.55%) ▲|MS203.52+1.10 (+0.54%) ▲|MSFT497.75+7.45 (+1.52%) ▲|MU977.50+50.95 (+5.50%) ▲|NEE81.28+0.91 (+1.13%) ▲|NFLX75.31-1.10 (-1.44%) ▼|NKE36.36+0.58 (+1.62%) ▲|NOW138.47-1.35 (-0.97%) ▼|NVDA219.34+5.44 (+2.54%) ▲|ORCL150.59+7.43 (+5.19%) ▲|PEP133.66-0.68 (-0.51%) ▼|PFE27.64+0.18 (+0.66%) ▲|PG147.55+0.53 (+0.36%) ▲|PLTR176.24+1.90 (+1.09%) ▲|PM190.48-1.23 (-0.64%) ▼|QCOM188.71+3.87 (+2.09%) ▲|RTX193.54-3.29 (-1.67%) ▼|SBUX96.67-0.67 (-0.69%) ▼|SCHW104.63-0.53 (-0.50%) ▼|SO86.76+0.53 (+0.61%) ▲|SPG204.47+1.53 (+0.75%) ▲|T25.39-0.47 (-1.82%) ▼|TMO658.32+9.89 (+1.53%) ▲|TMUS166.45-9.81 (-5.57%) ▼|TSLA366.20+8.12 (+2.27%) ▲|TXN258.14-2.53 (-0.97%) ▼|UBER70.87-0.10 (-0.14%) ▼|UNH375.21-0.05 (-0.01%) ▼|UNP282.48+1.56 (+0.56%) ▲|UPS100.17+1.40 (+1.42%) ▲|USB60.25+0.52 (+0.87%) ▲|V369.93-1.00 (-0.27%) ▼|VZ48.33-1.43 (-2.87%) ▼|WFC86.89-0.16 (-0.18%) ▼|WMT106.79-0.71 (-0.66%) ▼|XOM163.27-0.05 (-0.03%) ▼|
23.5 C
New York
Friday, September 18, 2026

Tag: data

European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea® (aflibercept)

REYKJAVIK, Iceland and LONDON, June 23, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human use (CHMP) adopted a positive opinion recommending approval for AVT06, Alvotech’s proposed biosimilar to Eylea® (aflibercept 2 mg). Based on a positive recommendation by CHMP, biosimilar medicines can be approved by the European Commission for marketing in the European Economic Area, that includes the 27 member states of the European Union, in addition to Norway, Iceland and Lichtenstein.

TARRAN at EUROBIKE 2025: try out the first intelligent e-cargo bike T1 Pro & explore the future of smart cycling

FRANKFURT, Germany, June 23, 2025 /PRNewswire/ -- Under the motto "Mind the Bike - Discover What's Next in Smart Cycling", the intelligent mobility company TARRAN...

European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea® (aflibercept)

REYKJAVIK, ICELAND and LONDON, UK (June 23, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human use (CHMP) adopted a positive opinion recommending approval for AVT06, Alvotech’s proposed biosimilar to Eylea® (aflibercept 2 mg). Based on a positive recommendation by CHMP, biosimilar medicines can be approved by the European Commission for marketing in the European Economic Area, that includes the 27 member states of the European Union, in addition to Norway, Iceland and Lichtenstein.

GAC Indonesia Smart Factory Commenced Operation with First AION V Produced

JAKARTA, Indonesia, June 23, 2025 /PRNewswire/ -- Recently, the GAC Indonesia Smart Factory was officially completed and commenced operations in Jakarta. Mr. Wei Haigang,...

AI Query Processing: Quantifying Carbon Footprint in Algorithmic Models

Artificial intelligence, particularly generative AI, is becoming integral to various aspects of daily life, from search engine optimization to automated email composition. However, the...

Fondaction’s share price set at $16.70

Highlights of the fiscal year ended May 31, 2025 Share value of $16.70, down $0.03 from the value established following the 6-month period ended November 30, 2024...

Trinasolar Releases 2024 Sustainability Report Highlighting Circular Innovation, Low-carbon Manufacturing, and Social Impact

CHANGZHOU, China, June 23, 2025 /PRNewswire/ -- Trinasolar, a global leader in smart PV and energy storage solutions, has officially released its 2024 Sustainability...

Risen Energy Highlights Advancements in Green Manufacturing, Sustainable Development and Corporate Responsibility in 2024 ESG Report

NINGBO, China, June 22, 2025 /PRNewswire/ -- Risen Energy Co., Ltd. (SZSE: 300118), a globally leading renewable energy company, recently released its 2024 Environmental,...

Toshiba Showcases Innovative SCiB™ Lithium-Ion Battery at ASIA Sustainable Energy Week 2025

Empowering Greener Transport, Logistics, and Infrastructure for a Decarbonized Future BANGKOK, June 23, 2025 /PRNewswire/ -- Toshiba Corporation announces its participation in ASIA Sustainable Energy Week 2025...

Risen Energy Highlights Advancements in Green Manufacturing, Sustainable Development and Corporate Responsibility in 2024 ESG Report

NINGBO, China, June 23, 2025 /PRNewswire/ -- Risen Energy Co., Ltd. (SZSE: 300118), a globally leading renewable energy company, recently released its 2024 Environmental,...

GoNetZero and Anvil Analytical Collaborate to Strengthen Carbon Tracking Across Global Supply Chains

SINGAPORE and LONDON, June 23, 2025 /PRNewswire/ -- GoNetZero, a global decarbonisation enabler in clean energy procurement and carbon management, is pleased to announce...

GoNetZero and Anvil Analytical Collaborate to Strengthen Carbon Tracking Across Global Supply Chains

SINGAPORE and LONDON, June 23, 2025 /PRNewswire/ -- GoNetZero, a global decarbonisation enabler in clean energy procurement and carbon management, is pleased to announce...

Unleash Your Inner Investor: Jessie Harper’s Take on Tesla’s Potential

Hey there, fabulous money mavens! 💁‍♀️ Let's dive into the world of Tesla and the optimistic forecasts made by Cathie Wood's Ark Invest. If...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsData